Mule Equine Parvovirus Hepatitis: Viral Liver Disease in Mules

Quick Answer
  • Equine parvovirus-hepatitis (EqPV-H) is the virus most strongly linked to Theiler’s disease, a sudden and potentially fatal hepatitis syndrome in equids.
  • Mules can be approached clinically much like horses when this disease is suspected, with concern centered on acute liver injury, jaundice, neurologic changes, and rapid decline.
  • Some infected equids show no outward signs, while others develop severe liver failure 4 to 13 weeks after receiving equine-origin biologic products such as plasma or antitoxin.
  • Diagnosis usually involves bloodwork for liver enzymes and liver function, plus PCR testing on blood and sometimes liver tissue.
  • There is no specific antiviral treatment. Care is supportive and may range from close monitoring to intensive hospitalization, depending on how sick the mule is.
Estimated cost: $350–$4,500

What Is Mule Equine Parvovirus Hepatitis?

Equine parvovirus-hepatitis, often shortened to EqPV-H, is a virus associated with acute hepatitis in equids. It is now considered the main cause of Theiler’s disease, also called serum hepatitis, a condition where the liver becomes suddenly inflamed and can fail very quickly. While most published research is in horses, the same viral disease framework is relevant when your vet is evaluating a mule with unexplained liver injury.

This condition matters because the liver supports energy balance, toxin removal, clotting, and brain function. When the liver is badly damaged, a mule may stop eating, become jaundiced, act dull or disoriented, or develop dangerous neurologic signs related to hepatic encephalopathy. In severe cases, death can occur within a few days after obvious signs appear.

Not every infected equid becomes critically ill. In fact, many infections appear to be subclinical, meaning bloodwork changes may happen without obvious symptoms. That is one reason your vet may recommend testing even if signs seem mild at first. Early recognition can help guide monitoring, supportive care, and decisions about referral.

Symptoms of Mule Equine Parvovirus Hepatitis

  • Poor appetite or sudden refusal to eat
  • Lethargy, depression, or reduced energy
  • Jaundice or yellowing of the gums, eyes, or skin
  • Behavior changes, dullness, or confusion
  • Head pressing, staggering, or incoordination
  • Blindness or apparent vision problems
  • Dark or discolored urine
  • Colic signs or lying down more than usual
  • Recumbency or inability to rise
  • Fever in some cases

See your vet immediately if your mule shows jaundice, neurologic changes, stumbling, head pressing, blindness, recumbency, or rapid worsening. These can be signs of severe liver dysfunction and hepatic encephalopathy. Even milder signs like poor appetite and lethargy deserve prompt attention if they appear after plasma, antitoxin, or another equine-origin biologic product in the prior 1 to 3 months.

Some equids with EqPV-H have no obvious symptoms at all and are found only because liver enzymes are elevated on bloodwork. That means your vet may recommend testing herd mates or monitoring other equids on the property if one animal is diagnosed.

What Causes Mule Equine Parvovirus Hepatitis?

EqPV-H is a hepatotropic virus, meaning it targets the liver. The best-established risk is exposure to equine-origin biologic products contaminated with the virus. Reported products in horses have included tetanus antitoxin, botulinum antitoxin, Streptococcus equi antiserum, pregnant mare serum, plasma products, and some other blood-derived materials. When disease follows this route, clinical signs often appear about 4 to 13 weeks later.

There also appears to be non-biologic transmission, meaning some equids become infected without a known history of receiving blood products. Researchers and equine infectious disease groups note that herd outbreaks can occur and that insect activity and management factors may play a role, but this route is still being studied. Shared needles are also considered a risk factor and should be avoided.

It is important to know that infection does not always equal severe disease. Many equids remain asymptomatic or develop only temporary liver enzyme elevations. A much smaller group develops clinical hepatitis, and a smaller subset progresses to fulminant liver failure. Your vet will help interpret whether a positive test likely reflects active disease, recent exposure, or a carrier state.

How Is Mule Equine Parvovirus Hepatitis Diagnosed?

Diagnosis starts with a careful history and exam. Your vet will want to know whether your mule received plasma, antitoxin, serum products, stem cell preparations, or other equine-origin biologics in the past few months. Bloodwork is usually the first step and often shows increased liver enzymes such as GGT, AST, SDH, or GLDH, along with changes in bilirubin, bile acids, glucose, ammonia, or clotting values when liver function is more severely affected.

Because several liver diseases can look similar, your vet may recommend a broader workup. This can include ultrasound, CBC and chemistry testing, liver function testing, and screening for toxins or other causes of hepatitis. PCR testing for EqPV-H can be performed on serum, plasma, whole blood, and in some cases liver tissue. If the diagnosis remains uncertain, a liver biopsy may help confirm the pattern and severity of injury.

In very sick mules, diagnosis and stabilization often happen at the same time. Neurologic signs, worsening jaundice, inability to eat, or recumbency may push your vet to recommend referral for intensive monitoring. Prognosis depends less on the test result alone and more on how much liver tissue has been damaged and whether the mule remains stable over the first several days.

Treatment Options for Mule Equine Parvovirus Hepatitis

Spectrum of Care means you have options. Here are treatment tiers at different price points.

Budget-Conscious Care

$350–$900
Best for: Stable mules with mild signs, limited budget, and access to frequent rechecks
  • Farm call or clinic exam with focused history
  • Basic bloodwork to assess liver injury and hydration
  • Repeat monitoring of liver enzymes if the mule is stable
  • Oral supportive care when safe and directed by your vet
  • Strict rest, low-stress handling, and close observation for neurologic changes
  • Avoidance of unnecessary medications metabolized by the liver
Expected outcome: Guarded to fair. Mild cases may recover with monitoring and supportive care, but sudden worsening is possible.
Consider: Lower upfront cost range, but less intensive monitoring may miss rapid progression. This option is not appropriate for neurologic, jaundiced, or collapsing patients.
Most Common

Recommended Standard Treatment

$900–$2,200
Best for: Most mules with suspected hepatitis that are sick enough to need active treatment but not yet in critical collapse
  • Full exam and serial chemistry testing for liver enzymes and function
  • CBC, bilirubin, bile acids, and additional blood tests as indicated
  • EqPV-H PCR testing on blood
  • Intravenous or enteral fluid support as directed by your vet
  • Nutritional support and management of hepatic encephalopathy risk
  • Hospitalization or day-stay monitoring depending on severity
Expected outcome: Variable. Mules that remain eating and clinically stable for several days may recover, while those with worsening neurologic signs have a more guarded outlook.
Consider: More diagnostics and monitoring improve decision-making, but the cost range is higher and referral may still become necessary if the mule declines.

Advanced / Critical Care

$2,200–$4,500
Best for: Mules with jaundice, neurologic signs, recumbency, severe anorexia, or rapidly worsening liver values
  • Referral hospital care or intensive inpatient monitoring
  • Frequent bloodwork, glucose checks, and clotting assessment
  • Aggressive IV fluid therapy with electrolyte and dextrose support when needed
  • Management of hepatic encephalopathy and recumbency complications
  • Ultrasound-guided liver evaluation and possible biopsy if safe
  • Isolation and herd-risk review when biologic exposure or outbreak concerns exist
Expected outcome: Guarded to poor in fulminant liver failure, though survivors can have a good long-term outlook once the acute crisis passes.
Consider: This tier offers the most monitoring and supportive options, but it requires transport, hospitalization, and a substantially higher cost range.

Cost estimates as of 2026-03. Actual costs vary by location, clinic, and individual case.

Questions to Ask Your Vet About Mule Equine Parvovirus Hepatitis

Bring these questions to your vet appointment to get the most out of your visit.

  1. You can ask your vet whether my mule’s signs fit acute hepatitis, hepatic encephalopathy, or another liver problem.
  2. You can ask your vet which blood tests best show how much liver function has been lost, not only how inflamed the liver is.
  3. You can ask your vet whether EqPV-H PCR testing is appropriate and what a positive result would mean in this case.
  4. You can ask your vet if any recent plasma, antitoxin, serum, or injectable products could have increased risk.
  5. You can ask your vet whether my mule is stable enough for farm management or needs hospitalization or referral.
  6. You can ask your vet what warning signs mean I should call immediately, especially behavior changes or stumbling.
  7. You can ask your vet how often liver values should be rechecked and which trends suggest recovery versus decline.
  8. You can ask your vet whether other equids on the property should be monitored or tested.

How to Prevent Mule Equine Parvovirus Hepatitis

There is no vaccine for EqPV-H at this time. Prevention focuses on reducing exposure to contaminated biologic products and limiting management risks that may spread blood-borne infection. When your mule needs plasma, antitoxin, or another equine-origin product, ask your vet whether the product is USDA-licensed and PCR-tested negative for EqPV-H. This is one of the most practical prevention steps available today.

Good injection hygiene also matters. Needles and syringes should never be shared between animals. If one equid on the property is diagnosed with suspected viral hepatitis, your vet may recommend monitoring herd mates with exams or bloodwork, because some infected equids can be asymptomatic carriers or develop only mild enzyme elevations.

If your mule has received a biologic product, stay alert for changes over the next 4 to 13 weeks. Poor appetite, jaundice, dark urine, or odd behavior should prompt a call to your vet right away. Early recognition cannot guarantee recovery, but it can help your vet start supportive care sooner and reduce avoidable stress during a liver crisis.

Find a Vet Near You